YABAO PHARMACEUTICAL GROUP CO.,LTD
As of 17 November 2026, for the company name YABAO PHARMACEUTICAL GROUP CO.,LTD as recorded, 4 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 47 records, across 40 drug names; the chemical-drug catalogue lists 16 active records with this name as holder; 51 active API registrations list this name as first registered company; 20 further acceptance records name it after the first applicant.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.
Drug filings
47 acceptance records as first applicant, grouped into 40 source drug names. Source data as of 2026/11/17.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Thioctic Acid Injection 2 records · Latest accepted 2026/07/13
Supplement · 2
小儿七星茶颗粒 · No verified English name 1 records · Latest accepted 2026/06/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2602411 | Supplement | 2026/06/01 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Promethazine Hydrochloride Injection 2 records · Latest accepted 2026/06/01
Generic · 2
银杏叶片 · No verified English name 1 records · Latest accepted 2026/05/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2602238 | Supplement | 2026/05/22 | YABAO PHARMACEUTICAL GROUP CO.,LTD; Chongqing Ke Rui Pharmaceutical (Group) Co., Ltd. romanized | CDE ↗ |
Nifedipine Controlled-release Tablets 2 records · Latest accepted 2026/05/07
Supplement · 1Generic · 1
东莨菪碱透皮贴片 · No verified English name 1 records · Latest accepted 2026/04/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2600045 | Generic | 2026/04/11 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Montmorillonite Powder 1 records · Latest accepted 2025/09/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503517 | Generic | 2025/09/25 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
三黄片 · No verified English name 1 records · Latest accepted 2025/08/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2501861 | Supplement | 2025/08/27 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
ZY-A002 · No verified English name 1 records · Latest accepted 2025/07/08
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZL2500046 | New drug | 2025/07/08 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
小儿多种维生素注射液(13) · No verified English name 1 records · Latest accepted 2025/06/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502241 | Generic | 2025/06/21 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Azithromycin for Suspension 1 records · Latest accepted 2025/06/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501199 | Supplement | 2025/06/14 | YABAO PHARMACEUTICAL GROUP CO.,LTD; Di Sha Pharma Group Co., Ltd. romanized | CDE ↗ |
牛黄解毒片 · No verified English name 1 records · Latest accepted 2025/06/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2501139 | Supplement | 2025/06/11 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Propranolol Hydrochloride Tablets 1 records · Latest accepted 2025/05/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501093 | Supplement | 2025/05/28 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
珍菊降压片 · No verified English name 1 records · Latest accepted 2025/04/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2500548 | Supplement | 2025/04/01 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Crisaborole Ointment 1 records · Latest accepted 2025/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500209 | Generic | 2025/01/10 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Phloroglucinol Injection 2 records · Latest accepted 2024/12/18
Supplement · 1Generic · 1
一清滴丸 · No verified English name 1 records · Latest accepted 2024/12/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2402451 | Supplement | 2024/12/10 | YABAO PHARMACEUTICAL GROUP CO.,LTD; Ya Bao Pharma Tai Yuan Pharmaceutical Co., Ltd. romanized | CDE ↗ |
护肝宁胶囊 · No verified English name 1 records · Latest accepted 2024/12/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2402446 | Supplement | 2024/12/10 | YABAO PHARMACEUTICAL GROUP CO.,LTD; Ya Bao Pharma Tai Yuan Pharmaceutical Co., Ltd. romanized | CDE ↗ |
柔肝解毒片 · No verified English name 1 records · Latest accepted 2024/12/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2402447 | Supplement | 2024/12/10 | YABAO PHARMACEUTICAL GROUP CO.,LTD; Ya Bao Pharma Tai Yuan Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Glibenclamide Tablets 1 records · Latest accepted 2024/12/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402095 | Supplement | 2024/12/10 | YABAO PHARMACEUTICAL GROUP CO.,LTD; Ya Bao Pharma Tai Yuan Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Isosorbide Dinitrate Tablets 1 records · Latest accepted 2024/12/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402094 | Supplement | 2024/12/10 | YABAO PHARMACEUTICAL GROUP CO.,LTD; Ya Bao Pharma Tai Yuan Pharmaceutical Co., Ltd. romanized | CDE ↗ |
阿司匹林缓释片 · No verified English name 1 records · Latest accepted 2024/12/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402098 | Supplement | 2024/12/10 | YABAO PHARMACEUTICAL GROUP CO.,LTD; Ya Bao Pharma Tai Yuan Pharmaceutical Co., Ltd. romanized | CDE ↗ |
ZY-A001 · No verified English name 1 records · Latest accepted 2024/11/23
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZL2400079 | New drug | 2024/11/23 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Isosorbide Mononitrate Extended-Release Tablets 1 records · Latest accepted 2024/11/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401925 | Supplement | 2024/11/20 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
人工牛黄甲硝唑胶囊 · No verified English name 1 records · Latest accepted 2024/11/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401879 | Supplement | 2024/11/13 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Metformin Hydrochloride Extended-release Tablets 1 records · Latest accepted 2024/11/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401878 | Supplement | 2024/11/13 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Pregabalin Capsules 2 records · Latest accepted 2024/11/05
Supplement · 2
诺氟沙星胶囊 · No verified English name 1 records · Latest accepted 2024/11/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401811 | Supplement | 2024/11/05 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Aspirin Enteric-coated Tablets 1 records · Latest accepted 2024/11/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401812 | Supplement | 2024/11/05 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
乳酸菌素片 · No verified English name 1 records · Latest accepted 2024/09/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401545 | Supplement | 2024/09/25 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
复方聚乙二醇电解质散(儿童型) · No verified English name 1 records · Latest accepted 2024/06/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401797 | Generic | 2024/06/14 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
硝苯地平缓释片(I) · No verified English name 1 records · Latest accepted 2023/10/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350745 | Supplement | 2023/10/07 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
银黄软胶囊 · No verified English name 1 records · Latest accepted 2023/09/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2301899 | Supplement | 2023/09/28 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Mosapride Citrate Tablets 1 records · Latest accepted 2023/01/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350089 | Supplement | 2023/01/29 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Citicoline Sodium Injection 2 records · Latest accepted 2022/12/31
Supplement · 2
消肿止痛贴 · No verified English name 1 records · Latest accepted 2022/08/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2200911 | Supplement | 2022/08/10 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Nifedipine Extended-Release Tablets 1 records · Latest accepted 2022/04/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200633 | Generic | 2022/04/22 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Amlodipine Besylate Tablets 1 records · Latest accepted 2022/01/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200176 | Supplement | 2022/01/21 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Thioctic Acid Tablets 2 records · Latest accepted 2021/12/30
Generic · 2
Mecobalamin Injection 1 records · Latest accepted 2021/01/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150034 | Supplement | 2021/01/15 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Changes in the last 90 days
0 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
Under review
4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Promethazine Hydrochloride Injection | CYHS2601244 | Generic | 2026/06/01 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Promethazine Hydrochloride Injection | CYHS2601243 | Generic | 2026/06/01 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Montmorillonite Powder | CYHS2503517 | Generic | 2025/09/25 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| 小儿多种维生素注射液(13) · No verified English name | CYHS2502241 | Generic | 2025/06/21 | YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
Catalogue holder records
16 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 复方聚乙二醇(3350)电解质散 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20263915 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Phloroglucinol Injection | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20253636 | 2025/03/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 硝苯地平缓释片(I) · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H14020439 | 2024/08/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nifedipine Controlled-release Tablets | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20244594 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mosapride Citrate Tablets | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20090158 | 2024/04/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Thioctic Acid Tablets | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20234571 | 2023/11/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 硝苯地平缓释片(II) · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20234505 | 2023/11/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Citicoline Sodium Injection | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20058333 | 2023/10/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Citicoline Sodium Injection | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20237134 | 2023/10/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fasudil Hydrochloride Injection | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20223364 | 2022/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mecobalamin Injection | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20063086 | 2022/02/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Mecobalamin Tablets | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20041767 | 2021/12/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Enalapril Maleate Tablets | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H14023577 | 2020/10/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Enalapril Maleate Tablets | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H14023578 | 2020/10/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Thioctic Acid Injection | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20203417 | 2020/08/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Thioctic Acid Tablets | YABAO PHARMACEUTICAL GROUP CO.,LTD | YABAO PHARMACEUTICAL GROUP CO.,LTD | 国药准字H20234570 | 2023/11/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
51 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 右泛醇 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20240001349 | A | 2026/06/11 | CDE ↗ |
| 克立硼罗 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20240000468 | A | 2025/11/14 | CDE ↗ |
| 盐酸阿考替胺 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20230001383 | I | 2024/01/10 | CDE ↗ |
| 格拉司琼 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20230001203 | A | 2026/07/07 | CDE ↗ |
| 布立西坦 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20230000692 | I | 2023/08/22 | CDE ↗ |
| 依折麦布 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20220000666 | A | 2026/02/10 | CDE ↗ |
| 琥珀酸曲格列汀 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20220000358 | A | 2024/05/28 | CDE ↗ |
| 间苯三酚三甲醚 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20210001278 | A | 2025/03/26 | CDE ↗ |
| 间苯三酚 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20210001279 | A | 2023/12/21 | CDE ↗ |
| 硝苯地平 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20210000565 | A | 2026/03/21 | CDE ↗ |
| 甲磺酸达比加群酯 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20200001375 | A | 2025/12/19 | CDE ↗ |
| 枸橼酸托法替布 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20200001114 | A | 2024/04/18 | CDE ↗ |
| 替格瑞洛 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20200000954 | A | 2022/11/04 | CDE ↗ |
| 盐酸法舒地尔 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20200000183 | A | 2025/12/19 | CDE ↗ |
| 双嘧达莫 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190009623 | A | 2025/07/28 | CDE ↗ |
| 盐酸普萘洛尔 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190009622 | A | 2025/07/28 | CDE ↗ |
| 普罗雌烯 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190008660 | A | 2025/08/07 | CDE ↗ |
| 盐酸洛美利嗪 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190008267 | A | 2023/03/24 | CDE ↗ |
| 硫普罗宁 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190008233 | A | — | CDE ↗ |
| 曲克芦丁 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190008013 | A | 2026/06/02 | CDE ↗ |
| 甘草酸二铵 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190007794 | A | 2025/04/22 | CDE ↗ |
| 枸橼酸莫沙必利 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190007421 | A | 2026/01/17 | CDE ↗ |
| 达卡巴嗪 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190007203 | A | 2023/06/02 | CDE ↗ |
| 盐酸氮芥 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190007201 | A | 2025/09/19 | CDE ↗ |
| 氢氯噻嗪 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190007043 | A | 2023/03/24 | CDE ↗ |
| 芦丁 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190007042 | A | 2025/09/23 | CDE ↗ |
| 三磷酸胞苷二钠 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190006659 | A | — | CDE ↗ |
| 氨来呫诺 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190005877 | A | 2025/09/06 | CDE ↗ |
| 甲磺酸左氧氟沙星 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190004613 | A | 2025/09/06 | CDE ↗ |
| 细辛脑 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190004595 | A | 2025/09/06 | CDE ↗ |
| 尼莫地平 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190004586 | A | 2026/03/31 | CDE ↗ |
| 硫酸双肼屈嗪 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190004585 | A | 2025/08/07 | CDE ↗ |
| 三硅酸镁 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190004584 | A | 2025/07/28 | CDE ↗ |
| 茴拉西坦 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190004582 | A | 2026/01/01 | CDE ↗ |
| 硫辛酸 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190004580 | A | 2026/01/08 | CDE ↗ |
| 氯喹那多 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190004578 | A | 2025/08/07 | CDE ↗ |
| 奥扎格雷 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190004567 | A | 2025/09/06 | CDE ↗ |
| 卡络磺钠 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190002329 | A | 2025/04/22 | CDE ↗ |
| 氢氧化铝 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190002315 | A | 2025/04/22 | CDE ↗ |
| 吡拉西坦 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190002314 | A | 2026/09/05 | CDE ↗ |
| 氯氮卓 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190002313 | A | 2025/04/22 | CDE ↗ |
| 盐酸氟桂利嗪 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190002312 | A | 2025/04/22 | CDE ↗ |
| 盐酸莫索尼定 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190002311 | A | 2025/04/22 | CDE ↗ |
| 甲钴胺 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190002307 | A | 2026/06/06 | CDE ↗ |
| 尼麦角林 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190002305 | A | 2025/04/22 | CDE ↗ |
| 非那雄胺 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190002304 | A | 2025/04/22 | CDE ↗ |
| 新鱼腥草素钠 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190002303 | A | 2025/04/22 | CDE ↗ |
| 甲苯磺酸索拉非尼 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20190000154 | A | 2025/09/06 | CDE ↗ |
| 苯甲酸阿格列汀 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20170001684 | A | 2026/07/04 | CDE ↗ |
| 盐酸异丙嗪 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20170000888 | A | 2024/07/06 | CDE ↗ |
| 依达拉奉 · No verified English name | YABAO PHARMACEUTICAL GROUP CO.,LTD | Y20170000196 | A | 2026/07/04 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
20 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 双氯芬酸钠盐酸利多卡因注射液 · No verified English name | CYHB2601682 | Supplement | 2026/09/04 | Zhong Yu Pharmaceutical (Haikou) Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Aspirin Enteric-coated Tablets | CYHS2602058 | Generic | 2026/08/19 | Shanxi Feng Fan Bo Kang Pharmaceuticals Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| 复方胃宁片 · No verified English name | CYZB2602127 | Supplement | 2026/05/18 | Shanxi Shi Dai Kang Hua Pharma Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| 银翘伤风胶囊 · No verified English name | CYZB2602111 | Supplement | 2026/05/18 | Shanxi Shi Dai Kang Hua Pharma Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| 利肺片 · No verified English name | CYZB2602110 | Supplement | 2026/05/18 | Shanxi Shi Dai Kang Hua Pharma Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Nimodipine Tablets | CYHS2600886 | Generic | 2026/04/17 | Beijing Ya Bao Bio Pharma Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| 儿童清咽解热口服液 · No verified English name | CYZB2502514 | Supplement | 2025/11/06 | Ya Bao Pharma Sichuan Pharmaceutical Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Verapamil Hydrochloride Injection | CYHS2503384 | Generic | 2025/09/12 | Shanghai Li Xiang Pharmaceutical Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| 利肺片 · No verified English name | CYZB2501630 | Supplement | 2025/08/02 | Shanxi Ming Yu Bio Technology Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| 双氯芬酸钠盐酸利多卡因注射液 · No verified English name | CYHS2502748 | Generic | 2025/07/30 | Shandong Ru Zhi Biopharmaceuticals Technology Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| 复方胃宁片 · No verified English name | CYZB2500503 | Supplement | 2025/03/25 | Shanxi Ming Yu Bio Technology Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Glucosamine Sulfate Capsules | CYHS2501098 | Generic | 2025/03/18 | Han Ma Si (Shanxi) Pharmaceuticals Technology Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Nitroglycerin Sublingual Tablets | CYHB2550071 | Supplement | 2025/01/22 | Chen Huan Pharmaceuticals Group Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| 银翘伤风胶囊 · No verified English name | CYZB2402607 | Supplement | 2024/12/26 | Shanxi Ming Yu Bio Technology Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Propranolol Hydrochloride Tablets | CYHB2450215 | Supplement | 2024/04/02 | Ya Bao Pharma Tai Yuan Pharmaceutical Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Phloroglucinol Injection | CYHS2303073 | Generic | 2023/11/09 | Ya Bao Pharma Sichuan Pharmaceutical Co., Ltd. romanized; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Sildenafil Citrate Tablets | JTH2300085 | Not stated by source | 2023/03/24 | Hetero Labs Limited; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Sildenafil Citrate Tablets | JTH2300084 | Not stated by source | 2023/03/24 | Hetero Labs Limited; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| Sildenafil Citrate Tablets | JTH2300083 | Not stated by source | 2023/03/24 | Hetero Labs Limited; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
| 东莨菪碱 · No verified English name | JTH2200231 | Not stated by source | 2022/11/18 | M/s ALCHEM INTERNATIONAL PRIVATE LIMITED; ALCHEM INTERNATIONAL PRIVATE LIMITED; YABAO PHARMACEUTICAL GROUP CO.,LTD | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/17
- Chemical-drug catalogue
- Last successful update: 2026/11/17
- API registrations
- Last successful update: 2026/11/17
- NMPA drug delivery notices
- Last successful update: 2026/11/17
Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.